Prostaglandin I2 analogs inhibit proinflammatory cytokine production and T cell stimulatory function of dendritic cells

Journal of Immunology

Volumn 178, Issue 2, 2007, Pages 702-710

  Zhou, Weisong ^a,f   Hashimoto, Koichi ^b   Goleniewska, Kasia ^a   O'Neal, Jamye F ^a   Ji, Shaoquan ^c   Blackwell, Timothy S ^a   FitzGerald, Garret A ^d   Egan, Karine M ^d   Geraci, Mark W ^e   Peebles Jr , R Stokes ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^c Linco Research Inc   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF COLORADO   (United States)

^f VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CICAPROST; CYCLIC AMP; CYTOKINE; FORSKOLIN; IBUPROFEN; ILOPROST; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOMETACIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 1ALPHA; INTERLEUKIN 5; INTERLEUKIN 6; ISOBUTYLMETHYLXANTHINE; LIPOPOLYSACCHARIDE; MACROPHAGE CHEMOTACTIC FACTOR; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OVALBUMIN; PROSTACYCLIN; PROSTACYCLIN RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNIPROST; AUTACOID; CD40 ANTIGEN; CD86 ANTIGEN; DIAGNOSTIC AGENT; DRUG DERIVATIVE; HLA ANTIGEN CLASS 2;

ALLERGIC REACTION; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CD4+ T LYMPHOCYTE; CELL FUNCTION; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; INFLAMMATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VIRUS INFECTION; ANIMAL; BIOSYNTHESIS; BONE MARROW; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECT; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM;

ANIMALS; ANTIGENS, CD40; ANTIGENS, CD86; BONE MARROW; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CYCLIC AMP; CYTOKINES; DENDRITIC CELLS; EPOPROSTENOL; HISTOCOMPATIBILITY ANTIGENS CLASS II; INFLAMMATION MEDIATORS; LYMPHOCYTE ACTIVATION; MICE; NF-KAPPA B; T-LYMPHOCYTES;

EID: 33846198409     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.2.702     Document Type: Article

References (63)

1. 2 receptor IP protects against respiratory syncytial virus-induced illness. J. Virol. 78: 10303-10309.
2. 2 in airway remodeling induced by repeated allergen challenge in mice. Am. J. Respir. Cell Mol. Biol. 29: 314-320.
3. Takahashi, Y., S. Tokuoka, T. Masuda, Y. Hirano, M. Nagao, H. Tanaka, N. Inagaki, S. Narumiya, and H. Nagai. 2002. Augmentation of allergic inflammation in prostanoid IP receptor deficient mice. Br. J. Pharmacol. 137: 315-322.
4. Boie, Y., T. H. Rushmore, A. Darmon-Goodwin, R. Grygorczyk, D. M. Slipetz, K. M. Metters, and M. Abramovitz. 1994. Cloning and expression of a cDNA for the human prostanoid IP receptor. J. Biol. Chem. 269: 12173-12178.
5. Nakagawa, O., I. Tanaka, T. Usui, M. Harada, Y. Sasaki, H. Itoh, T. Yoshimasa, T. Namba, S. Narumiya, and K. Nakao. 1994. Molecular cloning of human prostacyclin receptor cDNA and its gene expression in the cardiovascular system. Circulation 90: 1643-1647.
6. Luttmann, W., V. Herzog, H. Matthys, K. H. Thierauch, J. C. Virchow, and C. Kroegel. 1999. Modulation of cytokine release from mononuclear cells by prostacyclin, IL-4 and IL-13. Cytokine 11: 127-133.
7. Luttmann, W., V. Herzog, J. C. Virchow, Jr., H. Matthys, K. H. Thierauch, and C. Kroegel. 1996. Prostacyclin modulates granulocyte/macrophage colony-stimulating factor release by human blood mononuclear cells. Pulm. Pharmacol. 9: 43-48.
8. Eisenhut, T., B. Sinha, E. Grottrup-Wolfers, J. Semmler, W. Siess, and S. Endres. 1993. Prostacyclin analogs suppress the synthesis of tumor necrosis factor-α in LPS-stimulated human peripheral blood mononuclear cells. Immunopharmacology 26: 259-264.
9. 2 inhibits lipopolysaccharide-induced tumour necrosis factor-α generation. Br. J. Pharmacol. 122: 149-157.
10. Raychaudhuri, B., A. Malur, T. L. Bonfield, S. Abraham, R. J. Schilz, C. F. Farver, M. S. Kavuru, A. C. Arroliga, and M. J. Thomassen. 2002. The prostacyclin analogue treprostinil blocks NFκB nuclear translocation in human alveolar macrophages. J. Biol. Chem. 277: 33344-33348.
11. Cheng, Y., S. C. Austin, B. Rocca, B. H. Koller, T. M. Coffman, T. Grosser, I. A. Lawson, and G. A. FitzGerald. 2002. Role of prostacyclin in the cardiovascular response to thromboxane A2. Science 296: 539-541.
12. Blackwell, T. S., F. E. Yull, C. L. Chen, A. Venkatakrishnan, T. R. Blackwell, D. I. Hicks, L. H. Lancaster, J. W. Christman, and L. D. Kerr. 2000. Multiorgan nuclear factor κB activation in a transgenic mouse model of systemic inflammation. Am. J. Respir. Crit Care Med. 162: 1095-1101.
13. Sadikot, R. T., E. D. Jansen, T. R. Blackwell, O. Zoia, F. Yull, J. W. Christman, and T. S. Blackwell. 2001. High-dose dexamethasone accentuates nuclear factor-κB activation in endotoxin-treated mice. Am. J. Respir. Crit. Care Med. 164: 873-878.
14. Kretzschmar, M., M. Meisterernst, C. Scheidereit, G. Li, and R. G. Roeder. 1992. Transcriptional regulation of the HIV-1 promoter by NF-κB in vitro. Genes Dev. 6: 761-774.
15. Alcami, J., D. L. Lain, L. Folgueira, M. A. Pedraza, J. M. Jacque, F. Bachelerie, A. R. Noriega, R. T. Hay, D. Harrich, and R. B. Gaynor. 1995. Absolute dependence on κB responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytes. EMBO J. 14: 1552-1560.
16. Moses, A. V., C. Ibanez, R. Gaynor, P. Ghazal, and J. A. Nelson. 1994. Differential role of long terminal repeat control elements for the regulation of basal and Tat-mediated transcription of the human immunodeficiency virus in stimulated and unstimulated primary human macrophages. J. Virol. 68: 298-307.
17. Lutz, M. B., N. Kukutsch, A. L. Ogilvie, S. Rossner, F. Koch, N. Romani, and G. Schuler. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223: 77-92.
18. Dworski, R., J. R. Sheller, N. E. Wickersham, J. A. Oates, K. L. Brigham, L. J. Roberts, and G. A. FitzGerald. 1989. Allergen-stimulated release of mediators into sheep bronchoalveolar lavage fluid: effect of cyclooxygenase inhibition. Am. Rev. Respir. Dis. 139: 46-51.
19. Sadikot, R. T., W. Han, M. B. Everhart, O. Zoia, R. S. Peebles, E. D. Jansen, F. E. Yull, J. W. Christman, and T. S. Blackwell. 2003. Selective IκB kinase expression in airway epithelium generates neutrophilic lung inflammation. J. Immunol. 170: 1091-1098.
20. Moore, K. W., M. R. de Waal, R. L. Coffman, and A. O'Garra. 2001. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19: 683-765.
21. Nicod, L. P., F. el Habre, J. M. Dayer, and N. Boehringer. 1995. Interleukin-10 decreases tumor necrosis factor α and β in alloreactions induced by human lung dendritic cells and macrophages. Am. J. Respir. Cell Mol. Biol. 13: 83-90.
22. 2-induced IL-10 in bone marrow-derived dendritic cells. Cell Immunol. 228: 99-109.
23. Xia, C. Q., and K. J. Kao. 2003. Suppression of interleukin-12 production through endogenously secreted interleukin-10 in activated dendritic cells: involvement of activation of extracellular signal-regulated protein kinase. Scand. J. Immunol. 58: 23-32.
24. Wharton, J., N. Davie, P. D. Upton, M. H. Yacoub, J. M. Polak, and N. W. Morrell. 2000. Prostacyclin analogues differentially inhibit growth of distal and proximal human pulmonary artery smooth muscle cells. Circulation 102: 3130-3136.
25. Plum, J., C. Huang, B. Grabensee, K. Schror, and J. Meyer-Kirchrath. 2002. Prostacyclin enhances the expression of LPS/IFN-γ-induced nitric oxide synthase in human monocytes. Nephron 91: 391-398.
26. Dostmann, W. R., S. S. Taylor, H. G. Genieser, B. Jastorff, S. O. Doskeland, and D. Ogreid. 1990. Probing the cyclic nucleotide binding sites of cAMP-dependent protein kinases I and II with analogs of adenosine 3′,5′-cyclic phosphorothioates. J. Biol. Chem. 265: 10484-10491.
27. May, M. J., and S. Ghosh. 1997. Rel/NF-κB and IκB proteins: an overview. Semin. Cancer Biol. 8: 63-73.
28. Granucci, F., M. Foti, and P. Ricciardi-Castagnoli. 2005. Dendritic cell biology. Adv. Immunol. 88: 193-233.
29. Jozefowski, S., M. Bobek, and J. Marcinkiewicz. 2003. Exogenous but not endogenous prostanoids regulate cytokine secretion from murine bone marrow dendritic cells: EP2, DP, and IP but not EP1, EP3, and FP prostanoid receptors are involved. Int. Immunopharmacol. 3: 865-878.
30. Dinarello, C. A. 1997. Interleukin-1. Cytokine Growth Factor Rev. 8: 253-265.
31. Kopf, M., H. Baumann, G. Freer, M. Freudenberg, M. Lamers, T. Kishimoto, R. Zinkernagel, H. Bluethmann, and G. Kohler. 1994. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368: 339-342.
32. Gruss, H. J., and S. K. Dower. 1995. The TNF ligand superfamily and its relevance for human diseases. Cytokines Mol. Ther. 1: 75-105.
33. Gately, M. K., L. M. Renzetti, J. Magram, A. S. Stern, L. Adorini, U. Gubler, and D. H. Presky. 1998. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu. Rev. Immunol. 16: 495-521.
34. Lukacs, N. W. 2001. Role of chemokines in the pathogenesis of asthma. Nat. Rev. Immunol. 1: 108-116.
35. Moore, K. W., A. O'Garra, M. R. de Waal, P. Vieira, and T. R. Mosmann. 1993. Interleukin-10. Annu. Rev. Immunol. 11: 165-190.
36. + TH1-like responses. J. Clin. Invest. 98: 1010-1020.
37. Parry, G. C., and N. Mackman. 1997. Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-κB-mediated transcription. J. Immunol. 159: 5450-5456.
38. 2 enhances the production of endogenous IL-10, which down-regulates dendritic cell functions. J. Immunol. 168: 2255-2263.
39. 2 modulates dendritic cell function via EP2 and EP4 receptor subtypes. J. Leukocyte Biol. 73: 756-763.
40. Cong, Y., A. O. Oliver, and C. O. Elson. 2001. Effects of cholera toxin on macrophage production of co-stimulatory cytokines. Eur. J. Immunol. 31: 64-71.
41. Blackwell, T. S., L. H. Lancaster, T. R. Blackwell, A. Venkatakrishnan, and J. W. Christman. 1999. Differential NF-κB activation after intratracheal endotoxin. Am. J. Physiol. 277: L823-L830.
42. Baltathakis, I., O. Alcantara, and D. H. Boldt. 2001. Expression of different NF-κB pathway genes in dendritic cells (DCs) or macrophages assessed by gene expression profiling. J. Cell Biochem. 83: 281-290.
43. Ollivier, V., G. C. Parry, R. R. Cobb, D. de Prost, and N. Mackman. 1996. Elevated cyclic AMP inhibits NF-κB-mediated transcription in human monocytic cells and endothelial cells. J. Biol. Chem. 271: 20828-20835.
44. Conte, E., C. Bonaiuto, C. Nesci, N. Crimi, C. Vancheri, and A. Messina. 1997. Nuclear factor-κB activation in human monocytes stimulated with lipopoiysaccharide is inhibited by fibroblast conditioned medium and exogenous PGE2. FEBS Lett. 400: 315-318.
45. Farmer, P., and J. Pugin. 2000. β-Adrenergic agonists exert their "antiinflammatory" effects in monocytic cells through the IκB/NF-κB pathway. Am. J. Physiol. 279: L675-L682.
46. Parry, G. C., and N. Mackman. 1997. Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-κB-mediated transcription. J. Immunol. 159: 5450-5456.
47. Martin, M., K. Rehani, R. S. Jope, and S. M. Michalek. 2005. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat. Immunol. 6: 777-784.
48. Neumann, M., T. Grieshammer, S. Chuvpilo, B. Kneitz, M. Lohoff, A. Schimpl, B. R. Franza, Jr., and E. Serfling. 1995. RelA/p65 is a molecular target for the immunosuppressive action of protein kinase A. EMBO J. 14: 1991-2004.
49. 2 is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer. Blood 97: 3466-3469.
50. Luft, T., E. Maraskovsky, M. Schnurr, K. Knebel, M. Kirsch, M. Corner, R. Skoda, A. D. Ho, P. Nawroth, and A. Bierhaus. 2004. Tuning the volume of the immune response: strength and persistence of stimulation determine migration and cytokine secretion of dendritic cells. Blood 104: 1066-1074.
51. 2 regulates the migratory capacity of specific DC subsets. Blood 100: 1362-1372.
52. 2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. Blood 100: 1354-1361.
53. 2 is generally required for human dendritic cell migration and exerts its effect via EP2 and EP4 receptors. J. Immunol. 176: 966-973.
54. 2-EP4 signaling initiates skin immune responses by promoting migration and maturation of Langerhans cells. Nat. Med. 9: 744-749.
55. Honda, A., Y. Sugimoto, T. Namba, A. Watabe, A. Irie, M. Negishi, S. Narumiya, and A. Ichikawa. 1993. Cloning and expression of a cDNA for mouse prostaglandin E receptor EP2 subtype. J. Biol. Chem. 268: 7759-7762.
56. Regan, J. W., T. J. Bailey, D. J. Pepperl, K. L. Pierce, A. M. Bogardus, J. E. Donello, C. E. Fairbairn, K. M. Kedzie, D. F. Woodward, and D. W. Gil. 1994. Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype. Mol. Pharmacol. 46: 213-220.
57. 2 in limiting lung mucosal Th2, but not Th1, responses to inhaled allergen. J. Immunol. 169: 5997-6004.
58. Peebles, R. S., Jr., K. Hashimoto, J. D. Morrow, R. Dworski, R. D. Collins, Y. Hashimoto, J. W. Christman, K. H. Kang, K. Jarzecka, J. Furlong, et al. 2002. Selective cyclooxygenase-1 and -2 inhibitors each increase allergic inflammation and airway hyperresponsiveness in mice. Am. J. Respir. Crit. Care Med. 165: 1154-1160.
59. Peebles, R. S., Jr., R. Dworski, R. D. Collins, K. Jarzecka, D. B. Mitchell, B. S. Graham, and J. R. Sheller. 2000. Cyclooxygenase inhibition increases interleukin 5 and interleukin 13 production and airway hyperresponsiveness in allergic mice. Am. J. Respir. Crit. Care Med. 162: 676-681.
60. Spisni, E., G. Bartolini, M. Orlandi, B. Belletti, S. Santi, and V. Tomasi. 1995. Prostacyclin (PGI2) synthase is a constitutively expressed enzyme in human endothelial cells. Exp. Cell Res. 219: 507-513.
61. Morris, D. D., and J. N. Moore. 1987. Endotoxin-induced production of thromboxane and prostacyclin by equine peritoneal macrophages. Circ. Shock 23: 295-303.
62. Abramovitz, M., M. Adam, Y. Boie, M. Carriere, D. Denis, C. Godbout, S. Lamontagne, C. Rochette, N. Sawyer, N. M. Tremblay, et al. 2000. The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochim. Biophys. Acta 1483: 285-293.
63. Crider, J. Y., S. X. Xu, and N. A. Sharif. 2001. Pharmacology of functional endogenous IP prostanoid receptors in NCB-20 cells: comparison with binding data from human platelets. Prostaglandins Leukot. Essent. Fatty Acids 65: 253-258.